NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-050-2000-0-DE-20 Geldanamycin Derivative and Method of Treating Cancer Using Same DE EP 02757908.5 Expired
NCI E-050-2000-0-GB-25 Geldanamycin Derivative and Method of Treating Cancer Using Same GB EP 02757908.5 Expired
NCI E-050-2000-0-TR-35 Geldanamycin Derivative and Method of Treating Cancer Using Same TR EP 02757908.5 Expired
NCI E-050-2000-0-SE-34 Geldanamycin Derivative and Method of Treating Cancer Using Same SE EP 02757908.5 Expired
NCI E-050-2000-0-PT-33 Geldanamycin Derivative and Method of Treating Cancer Using Same PT EP 02757908.5 Expired
NCI E-050-2000-0-CH-18 Geldanamycin Derivative and Method of Treating Cancer Using Same CH EP 02757908.5 Expired
NCI E-050-2000-0-ES-22 Geldanamycin Derivative and Method of Treating Cancer Using Same ES EP 02757908.5 Expired
NCI E-050-2000-0-IT-28 Geldanamycin Derivative and Method of Treating Cancer Using Same IT EP 02757908.5 Expired
NCI E-050-2000-0-IE-27 Geldanamycin Derivative and Method of Treating Cancer Using Same IE EP 02757908.5 Expired
NCI E-050-2000-0-GR-26 Geldanamycin Derivative and Method of Treating Cancer Using Same GR EP 02757908.5 Expired
NCI E-050-2000-0-EP-03 Geldanamycin Derivative and Method of Treating Cancer Using Same EP National Stage 02757908.5 Expired
NCI E-050-2000-0-CN-14 Geldanamycin Derivative and Use Thereof for Preparing a Medicament for Treating Cancers CN National Stage 02803465.1 Expired
NCI E-050-2000-0-SI-13 Geldanamycin Derivative And Method of Treating Cancer Using Same SI National Stage P200220013 Abandoned
NCI E-050-2000-0-ZA-08 Geldanamycin Derivative And Method of Treating Cancer Using Same ZA National Stage 2003/04178 Expired
NICHD E-089-2001-0-PCT-02 USE OF HEPRPESVIRUSES, PROTEINS AND NUCLEIC ACIDS ENCODING THE PROTIENS TO INHIBIT CCR5-TROPIC HIV-1 INFECTION AND REPLICATION PCT PCT PCT/US02/10048 Expired
NHLBI E-198-2000-0-PCT-02 Ghost Artifact Cancellation Using Phased Array Processing PCT PCT PCT/US2002/009939 Expired
NCI E-050-2000-0-PCT-02 Geldanamycin Derivative And Method of Treating Cancer Using Same PCT PCT PCT/US2002/010097 Expired
NHLBI E-198-2000-0-AU-03 Ghost Artifact Cancellation Using Phased Array Processing AU National Stage 2002247451 Abandoned
NIA E-134-2001-0-PCT-02 Level Coil Sensor For Respiratory and Cardiac Motion PCT PCT PCT/US02/09957 Expired
NIA E-134-2001-0-EP-03 Lever-Coil Sensor For Respiratory And Cardiac Motion EP National Stage 02757888.9 Abandoned
NIA E-134-2001-0-AU-05 Lever-Coil Sensor For Respiratory And Cardiac Motion AU National Stage 2002306995 Abandoned
NCI E-243-1999-0-US-07 FIBROBLAST GROWTH FACTOR-5 (FGF-5) IS A TUMOR ASSOCIATED T-CELL ANTIGEN US National Stage 10/089,485 Abandoned
NIA E-134-2001-0-CA-04 Lever-Coil Sensor For Respiratory And Cardiac Motion CA National Stage 2442164 Abandoned
NCI E-137-2002-0-US-01 METHODS FOR TREATING CANCER IN HUMANS US 60/368,438 Abandoned
NCI E-126-2002-0-US-01 Comparative Fluorimetric Hybridization of Consensus Versus Test Sample for the Detection of Known and Unknown Single Nucleotide Variants... US 60/369,073 Abandoned
NCI E-105-1999-0-US-07 Phenylalanine Derivatives US National Stage 09/937,150 7226991 Abandoned PDF
NIDA E-026-1994-0-US-02 IMMUNOPHILIN-BINDING AGENTS PREVENT GLUTAMATE NEUROTOXICITY ASSOCIATED WITH VASCULAR STROKE AND NEURODEGENERATIVE DISEASES US CON 10/105,943 Abandoned
NIDDK E-155-2001-0-US-01 Cyr61 as a Biomarker / Clinical Laboratory Test / Treatment For Acute Renal Failure US 60/367,411 Abandoned
NCI E-074-1999-3-CA-05 Glycosylation-Resistant Cyanovirins and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods Of Production and Methods of Using Nonglycosylated Cyanovirins CA National Stage 2441287 Abandoned
NCI E-126-2001-0-CA-04 Human Papilloma Virus Immunoreactive Peptides CA National Stage 2441947 Abandoned
NIAID E-293-1999-0-US-06 Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors US National Stage 10/088,952 7468352 Abandoned PDF
NCI E-074-1999-3-BE-12 Glycosylation-Resistant Cyanovirins and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Using Nonglycosylated Cyanovirins BE EP 02723611.6 Abandoned
NCI E-074-1999-3-EP-03 Glycosylation-Resistant Cyanovirins and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Using Nonglycosylated Cyanovirins EP National Stage 02723611.6 Abandoned
NCI E-074-1999-3-FR-11 Glycosylation-Resistant Cyanovirins and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Using Nonglycosylated Cyanovirins FR EP 02723611.6 Abandoned
NCI E-074-1999-3-DE-10 Glycosylation-Resistant Cyanovirins and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Using Nonglycosylated Cyanovirins DE EP 02723611.6 Abandoned
NCI E-074-1999-3-GB-14 Glycosylation-Resistant Cyanovirins and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Using Nonglycosylated Cyanovirins GB EP 02723611.6 Abandoned
NCI E-074-1999-3-CH-13 Glycosylation-Resistant Cyanovirins and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Using Nonglycosylated Cyanovirins CH EP 02723611.6 Abandoned
NCI E-074-1999-3-AU-04 Glycosylation-Resistant Cyanovirins And Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods Of Production and Methods of Using Nonglycosylated Cyanovirins AU National Stage 2002254382 Abandoned
NCI E-126-2001-0-AU-06 Human Papilloma Virus Immunoreactive Peptides AU National Stage 2002258614 Abandoned
NCI E-126-2001-0-PCT-02 Human Papilloma Virus Immunoreactive Peptides PCT PCT PCT/US2002/009261 Expired
NCI E-074-1999-3-PCT-02 Glycosylation-Resistant Cyanovirins And Related Conjugates, Composi- tions, Nucleic Acids, Vectors, Host Cells, Methods Of Production... PCT PCT PCT/US02/09277 Expired
NIMH E-171-2001-0-PCT-02 METHODS FOR TREATING NEURODEGENERATIVE DISEASES INCLUDING ALZHEMER'S PCT PCT PCT/US02/08619 Expired
NCI E-126-2001-0-EP-05 Human Papilloma Virus Immunoreactive Peptides EP National Stage 02728570.9 Abandoned
NIMH E-171-2001-0-CA-03 METHODS FOR TREATING NEURODEGENERATIVE DISEASES INCLUDING ALZHEMER'S CA National Stage 2442003 Abandoned
NIA E-183-2003-0-US-01 Method For Treating Cognitve Disorders US 60/367,068 Abandoned
NCI E-002-2002-0-US-01 Material And Methods For Inhibiting WIP1 US 60/366,883 Abandoned
NCI E-110-1999-0-US-03 Extracellular cAMP-Dependent Protein Kinase in the Diagnosis and Prognosis And Treatment of Cancer US National Stage 10/018,396 Abandoned
NEI E-220-2001-0-BR-03 Nutritional Supplement to Treat Macular Degeneration BR National Stage PI0208640-9 Abandoned
NEI E-220-2001-0-BE-48 Nutritional Supplement to Treat Macular Degeneration BE EP 04025722.2 Expired
NEI E-220-2001-0-ES-50 Nutritional Supplement to Treat Macular Degeneration ES EP 04025722.2 Expired